Allogene Corporate Overview November 2025 Legal Disclaimers This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. To the extent that statements contained in this presentation are not descriptions of historical facts regarding Allogene Therapeutics, Inc. ("Allogene," "we," "us," or "our"), they are forward-looking statements reflecting management's current beliefs and expectations. Forward-looking statem ...

Financial Performance - Revenue in 3Q25 reached $1273 million, with a 121% organic growth at constant currency year-over-year[23] - Adjusted EBITDA margin was 185% in 3Q25[23] - Adjusted profit margin was 89% in 3Q25[23] - Cash generated from operating activities in 9M25 was $465 million, with an operating cash flow/adjusted EBITDA of 718%[72] - Adjusted diluted EPS in 3Q25 was $009, a 16% year-over-year increase[77] Growth and Expansion - CI&Ters grew by 163% year-over-year, reaching 7,858 employees[31, 33] - The company is expanding its people platform for growth[30] - The company has a diversified revenue base, with financial services contributing 36%, consumer goods 20%, retail and industrial goods 21%, tech and telecom 10%, life sciences 8%, and others 5% of the total revenue in 9M25[61] - Latin America accounts for 47%, North America 44%, and new markets 10% of the total revenue by geography in 9M25[61] AI and Technology - CI&T is driving AI adoption internally, with rapid growth in its library of agents and adoption by CI&Ters[35, 36] - 85% adoption across CI&Ters with 64% daily active CI&Ters[38, 39]

Financial Performance - Q1 FY2026 revenue reached $14883 million, up 8% year-over-year[9, 26, 32, 33] - Non-GAAP EPS was $1.00, a 10% increase year-over-year[9] - Non-GAAP gross margin was 68.1%[9] - Non-GAAP operating margin was 34.4%[9] AI Momentum - Cisco secured $1300 million in AI infrastructure orders from hyperscale customers in Q1 FY26[6, 9, 18] - AI orders of over $200 million were taken from neocloud, sovereign, and enterprise customers in Q1 FY26[6, 18] - The company anticipates over $3000 million in AI infrastructure revenues in FY26[6, 12] - The AI opportunities pipeline is growing, exceeding $2000 million across neocloud, sovereign, and enterprise customers[9, 15] Recurring Revenue - Total RPO increased by 7% year-over-year to $42900 million, with product RPO up 10% year-over-year[9, 27] - Total ARR grew by 5% year-over-year to $31400 million, with product ARR up 7% year-over-year[9, 27] Capital Allocation - Cisco returned $3600 million to shareholders in Q1 FY26, including $2001 million in share repurchases[9, 35]

Financial Performance & Growth - 2024 Revenue was $3.4 billion[14] - 2024 Adjusted EBITDA was $761 million[15] - 2024 Adjusted EPS was $1.39[22] - Q3 2025 Revenue reached $856 million, a 3% year-over-year increase[27] - Q3 2025 Adjusted EBITDA margin improved by 90 basis points year-over-year to 22.9%[28] - Q3 2025 Adjusted EPS increased by 18% year-over-year to $0.39[28] Market Opportunities & Strategy - The company anticipates double-digit core growth in growth markets[38] - The company expects Personal Mobility revenue to more than double by 2028, with a Compound Annual Growth Rate (CAGR) of approximately 30%[41, 58] - The company sees a potential revenue opportunity of approximately $100 million to $200 million by 2028 from liquid-cooled Data Center applications[58] Financial Targets & Outlook - The company is on track to deliver its mid-term Adjusted EBITDA margin target in 2027[50] - The company anticipates end markets to recover in 2026, driving incremental earnings growth[58]

Financial Performance - Ibotta's Q3 2025 revenue reached $83.3 million, exceeding the guidance midpoint of $81.5 million by 2%[15] - Adjusted EBITDA for Q3 2025 was $16.6 million, surpassing the guidance midpoint of $11.5 million by 44%[15] - Total revenue experienced a year-over-year decline of 16%[19] - Adjusted EBITDA margin decreased by 17 percentage points year-over-year[19] Revenue Breakdown - Redemption revenue accounted for 87% of the total revenue in Q3 2025[23] - Within redemption revenue, 59% was attributed to third-party publishers (3PP) and 27% to direct-to-consumer (D2C)[23] - D2C redemption revenue decreased by 31% year-over-year[46] - Third-party publisher (3PP) redemption revenue decreased by 4% year-over-year[41] Q4 2025 Guidance - The company projects revenue between $80.0 million and $85.0 million, representing a 16% year-over-year decline at the midpoint[53] - Adjusted EBITDA is expected to be between $9.0 million and $12.0 million, with a 13% margin at the midpoint[53]

Financial Performance Highlights - Alliance Entertainment's EBITDA soared to $122 million in Q1 FY26, a 259% year-over-year increase from $34 million[11] - Net income increased significantly from $04 million to $49 million[41, 137] - Adjusted EBITDA increased from $34 million to $122 million, a 258% increase year-over-year[43, 134] - Gross Margin increased by 340 basis points to 146%[133] Revenue and Sales - Alliance Entertainment drives over $1 billion in annual revenue across diverse categories[22] - Revenue for the twelve months ended September 30, 2025, was $1088 million[25] - Q1 FY26 revenue increased to $254 million from $229 million in Q1 FY25[32] - Direct-to-consumer (DTC) contributes 37% of Alliance Entertainment's net revenue[58] Balance Sheet - Inventory rose from $1028 million to $1217 million, reflecting holiday build[30, 135] - The Revolving Credit Facility, Net balance improved from $88 million to $56 million year-over-year[135] Strategic Initiatives and Partnerships - Alliance Entertainment has signed an exclusive multi-year Home Video and Digital Rights License Agreement with The Horror Section Inc[11] - Alliance Entertainment is the Category Advisor for Walmart's video category[63] - Exclusive distribution and licensing agreements drive annual sales exceeding $365 million[68]

INNOVATE Corp. Q3 2025 Earnings Release Supplement November 12, 2025 INNOVATE Corp. 2025 Safe Harbor Disclaimers Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains, and certain oral statements made by our representatives from time to time may contain, "forward-looking statements." Generally, forward-looking statements include information describing actions, events, results, strategies and expe ...

November 12, 2025 Third Quarter Financial and Business Update 1 DISCLAIMERS Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, our clinical results and other future c ...

Business Overview - 374Water's AirSCWO system is designed to destroy organic wastes and produce safe water, mineral effluents, vent gas, and recoverable heat energy[8] - The company estimates a $450 billion+ global addressable market, driven by new EPA regulations[8] - The company plans to establish Waste Destruction Services (WDS) at a RCRA Part B TSDF in mid-2026[8] Operational Highlights - 374Water completed a Department of Defense (DoD) project in Detroit, Michigan, with Arcadis and Clean Earth, aimed at identifying commercial-scale technology solutions to destroy PFAS contaminated wastes[9] - The company is preparing for AirSCWO system deployment to Orange County Sanitation (OC San) in Fountain Valley, CA, targeting a late Q4 2025 or early Q1 2026 start-up[9] - 374Water entered into an agreement for the sale and deployment of an AirSCWO 6 system with Olathe, Kansas[9] - The company began processing the first phase of its award by the State of North Carolina to destroy up to 29,000 gallons of Aqueous Film Forming Foam (AFFF) using AirSCWO technology[9] - The company fortified its balance sheet with a new at-the-market facility, resulting in gross proceeds of approximately $7 million, extending cash runway into the second quarter of 2026[9] Financial Performance - For the three months ended September 30, 2025, 374Water reported revenue of $0.8 million, compared to $0.08 million in 2024[20] - Gross profit for the same period was $0.2 million in 2025, compared to a deficit of $0.04 million in 2024[20] - Cash and cash equivalents as of September 30, 2025, were $0.9 million, compared to $10.7 million as of December 31, 2024[20] Future Projections - 374Water projects revenue in the range of $6-8 million for 2026[24] - The company anticipates sales/lease/WDS to be in the range of $10-12 million in 2027, increasing to $15-20 million in 2028, and $25-30 million in 2029/2030[21]

Electromed, Inc. Investor Presentation November 12, 2025 NYSE American: ELMD Innovation Leader in Airway Clearance Technologies Investor Presentation | 2 Electromed – Who We Are Electromed, Inc. is a growing medical device company focused on airway management to help people around the world breathe better, stay healthier, and lead active and fulfilling lives. *As of and for 12 months ended 9/30/2025 Key Stats: Headquarters: New Prague, MN Ticker: ELMD Established: 1992 Annual Revenue: $66.2M* Market Cap: $2 ...